Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

FDA Launches Assessment of BHA, a Common Food Chemical Preservative

The FDA has launched a comprehensive re-assessment of butylated hydroxyanisole (BHA), a chemical preservative used in food. The review will consider whether BHA is safe under its current conditions of use in food and as a food contact substance, based on the latest scientific information. As part of this re-assessment, the agency issued a Request for Information on the use and safety of BHA.

This is part of the FDA’s broader efforts to proactively review chemical additives in the food supply. In May 2025, the FDA launched a strengthened program to review chemicals currently in the food supply. The FDA identified BHA as a top priority for review. The FDA’s post-market assessment of BHA used in food is one of several ongoing post-market assessments under the agency’s enhanced systematic process for scrutinizing chemicals in our food supply.

“BHA has remained in the food supply for decades despite being identified by the National Toxicology Program as ‘reasonably anticipated to be a human carcinogen’ based on animal studies,” said Health and Human Services Secretary Robert F. Kennedy, Jr. “This reassessment marks the end of the ‘trust us’ era in food safety. If BHA cannot meet today’s gold-standard science for its current uses, we will remove it from the food supply and continue cleaning up food chemicals—starting where children face the greatest exposure.”

The FDA listed BHA as Generally Recognized as Safe (GRAS) in 1958 and approved it as a food additive in 1961. It is used to prevent spoilage of fats and oils and can be found in various food products including frozen meals, breakfast cereals, cookies, candy, ice cream, and meat products. While packaged food label data indicate BHA use has declined in recent years, it remains present in many food products, including those marketed to children.

“We are taking decisive action to ensure that chemicals in our food supply are not causing harm,” said FDA Commissioner Marty Makary, M.D., M.P.H. “The scientific community has raised significant concerns about some chemicals currently in the food supply. Once we complete our assessment of BHA, we expect to conduct similar assessments for butylated hydroxytoluene, a synthetic preservative known as BHT, and azodicarbonamide — a chemical used in yoga mats and also used as a dough conditioner.”

“The FDA is committed to ensuring the safety of chemicals in our food supply through rigorous, science-based evaluation,” said Kyle Diamantas, Deputy Commissioner for Human Foods. “This comprehensive post-market assessment of BHA reflects our proactive approach to food safety and our dedication to protecting public health by continuously reviewing the latest scientific evidence.”

For decades, health advocates have raised potential safety concerns regarding the use of BHA. The National Institute of Health’s National Toxicology Program lists BHA as “reasonably anticipated to be a human carcinogen” based on animal studies. BHA was recommended for re-assessment in several comments submitted to the public meeting docket for the Development of an Enhanced Systematic Process for the FDA’s Post-Market Assessment of Chemicals in Food that closed in January 2025.

The Make America Healthy Again Commission’s Strategy Report identified as a key priority the post market review of chemical additives in food, including food additives, food contact substances, GRAS substances, and color additives. The FDA has advanced draft rulemaking to reform its GRAS framework in an effort to drive greater transparency into the food supply by addressing independent GRAS conclusions and bringing greater oversight into the review of chemicals added to food.  

For more information about the Request for Information on BHA, visit List of Select Chemicals in the Food Supply Under FDA Review | FDA.

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.